Richarte, Vanesa
Sánchez-Mora, Cristina
Corrales, Montserrat
Fadeuilhe, Christian
Vilar-Ribó, Laura http://orcid.org/0000-0001-8758-523X
Arribas, Lorena
Garcia, Estela
Rosales-Ortiz, Silvia Karina
Arias-Vasquez, Alejandro
Soler-Artigas, María http://orcid.org/0000-0002-3213-1107
Ribasés, Marta http://orcid.org/0000-0003-1039-1116
Ramos-Quiroga, Josep Antoni http://orcid.org/0000-0003-1622-0350
Article History
Received: 4 February 2021
Accepted: 24 June 2021
First Online: 8 July 2021
Competing interests
: Dra. Sánchez-Mora, Dra. Soler Artigas, Estela García, and Dra. Ribasés report no biomedical financial interests or potential conflicts of interest. Vanesa Richarte has served as a speaker for Rubió and Shire/Takeda in the last 5 years. She has received travel awards from Shire/Takeda for participating in psychiatric meetings. The ADHD Program received unrestricted educational and research support from Eli Lilly and Co., Janssen-Cilag, Shire/Takeda, Rovi, Psious, and Laboratorios Rubió in the past two years. Dra. Corrales received travel awards from Shire for participating in psychiatric meetings. Christian Fadeuilhe received travel awards from Rubió, Shire/Takeda, and Lundbeck for participating in psychiatric meetings. Prof. Ramos-Quiroga was on the speakers’ bureau and/or acted as a consultant for Eli-Lilly, Janssen-Cilag, Novartis, Shire, Takeda, Bial, Shionogui, Lundbeck, Almirall, Braingaze, Sincrolab, Medice, and Rubió in the last 5 years. He also received travel awards (air tickets + hotel) from Janssen-Cilag, Rubió, Shire, Takeda, Shionogui, Bial, Medice, and Eli-Lilly for participating in psychiatric meetings. The Department of Psychiatry chaired by him received unrestricted educational and research support from the following companies in the last 5 years: EliLilly, Lundbeck, Janssen- Cilag, Actelion, Shire, Ferrer, Oryzon, Roche, Psious, and Rubió.